US Stock MarketDetailed Quotes

IVBIY INNOVENT BIOLOGICS INC UNSPON ADS EACH REP 4 ORD SHS

Watchlist
  • 19.150
  • 0.0000.00%
15min DelayClose Nov 21 16:00 ET
7.80BMarket Cap-43.03P/E (TTM)

INNOVENT BIOLOGICS INC UNSPON ADS EACH REP 4 ORD SHS Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
(FY)Dec 31, 2016
Total revenue
36.21%6.21B
6.71%4.56B
11.08%4.27B
266.94%3.84B
10,953.34%1.05B
-48.88%9.48M
18.54M
0
Operating revenue
36.21%6.21B
6.71%4.56B
11.08%4.27B
266.94%3.84B
10,953.34%1.05B
-48.88%9.48M
--18.54M
--0
Cost of revenue
22.05%1.14B
84.23%930.99M
30.32%505.34M
210.51%387.76M
124.88M
0
Gross profit
39.84%5.07B
-3.69%3.63B
8.92%3.76B
274.58%3.46B
9,635.64%922.65M
9.48M
Operating expense
-3.68%5.98B
8.83%6.21B
63.03%5.7B
58.94%3.5B
40.91%2.2B
142.84%1.56B
55.65%643.27M
413.27M
Selling and administrative expenses
12.40%3.85B
0.00%3.43B
92.73%3.43B
87.56%1.78B
129.21%947.81M
371.14%413.51M
52.96%87.77M
--57.38M
-Selling and marketing expense
19.68%3.1B
-1.12%2.59B
95.41%2.62B
93.62%1.34B
409.18%692.52M
1,542.98%136.01M
--8.28M
----
-General and administrative expense
-10.20%750.28M
3.66%835.49M
84.50%806.01M
71.12%436.87M
-8.00%255.3M
249.10%277.5M
38.53%79.49M
--57.38M
Research and development costs
-22.42%2.23B
23.63%2.87B
25.44%2.32B
43.00%1.85B
5.98%1.29B
99.65%1.22B
59.08%611.92M
--384.65M
Operating profit
64.79%-909.21M
-33.15%-2.58B
-4,468.83%-1.94B
96.68%-42.44M
17.65%-1.28B
-148.52%-1.55B
-51.17%-624.73M
-413.27M
Net non-operating interest income expense
303.25%354.21M
-1.63%87.84M
86.99%89.29M
10.51%47.75M
189.48%43.21M
1.93%-48.29M
0.03%-49.24M
-49.26M
Non-operating interest income
138.92%452.84M
24.90%189.54M
30.71%151.76M
13.05%116.1M
396.66%102.7M
159.06%20.68M
75.81%7.98M
--4.54M
Non-operating interest expense
-3.02%98.62M
62.81%101.7M
-8.61%62.46M
14.89%68.35M
-13.74%59.49M
20.52%68.97M
6.37%57.23M
--53.8M
Other net income (expense)
Special income (charges)
-1,686.67%-952K
108.46%60K
40.92%-709K
---1.2M
--0
---3.32M
--0
--0
-Less:Other special charges
1,686.67%952K
-108.46%-60K
-40.92%709K
--1.2M
----
--3.32M
----
----
Other non- operating income (expenses)
-56.83%-680.09M
39.56%-433.64M
-86.80%-717.42M
23.15%-384.06M
88.48%-499.73M
-8,403.80%-4.34B
58.59%-51.01M
---123.2M
Income before tax
47.27%-1.14B
17.84%-2.17B
-207.64%-2.64B
50.07%-858.71M
70.71%-1.72B
-720.19%-5.87B
-31.52%-716.05M
-544.46M
Income tax
-1,423.69%-116.5M
-89.89%8.8M
-37.70%87.04M
139.71M
0
Net income
52.83%-1.03B
20.14%-2.18B
-173.31%-2.73B
41.95%-998.42M
70.71%-1.72B
-720.19%-5.87B
-31.52%-716.05M
-544.46M
Net income continuous Operations
52.83%-1.03B
20.14%-2.18B
-173.31%-2.73B
41.95%-998.42M
70.71%-1.72B
-720.19%-5.87B
-31.52%-716.05M
---544.46M
Minority interest income
33.98%-101.49M
-281.92%-153.73M
-40.25M
Net income attributable to the parent company
52.83%-1.03B
20.14%-2.18B
-173.31%-2.73B
41.95%-998.42M
70.20%-1.72B
-926.38%-5.77B
-11.53%-562.32M
-504.2M
Preferred stock dividends
0
Other preferred stock dividends
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
52.83%-1.03B
20.14%-2.18B
-173.31%-2.73B
41.95%-998.42M
70.20%-1.72B
-926.38%-5.77B
-11.53%-562.32M
-504.2M
Basic earnings per share
54.79%-2.64
22.34%-5.84
-154.05%-7.52
49.32%-2.96
91.53%-5.84
-3,328.12%-68.96
-11.53%-2.0116
-1.8037
Diluted earnings per share
54.79%-2.64
22.34%-5.84
-154.05%-7.52
49.32%-2.96
91.53%-5.84
-3,328.12%-68.96
-11.53%-2.0116
-1.8037
Dividend per share
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017(FY)Dec 31, 2016
Total revenue 36.21%6.21B6.71%4.56B11.08%4.27B266.94%3.84B10,953.34%1.05B-48.88%9.48M18.54M0
Operating revenue 36.21%6.21B6.71%4.56B11.08%4.27B266.94%3.84B10,953.34%1.05B-48.88%9.48M--18.54M--0
Cost of revenue 22.05%1.14B84.23%930.99M30.32%505.34M210.51%387.76M124.88M0
Gross profit 39.84%5.07B-3.69%3.63B8.92%3.76B274.58%3.46B9,635.64%922.65M9.48M
Operating expense -3.68%5.98B8.83%6.21B63.03%5.7B58.94%3.5B40.91%2.2B142.84%1.56B55.65%643.27M413.27M
Selling and administrative expenses 12.40%3.85B0.00%3.43B92.73%3.43B87.56%1.78B129.21%947.81M371.14%413.51M52.96%87.77M--57.38M
-Selling and marketing expense 19.68%3.1B-1.12%2.59B95.41%2.62B93.62%1.34B409.18%692.52M1,542.98%136.01M--8.28M----
-General and administrative expense -10.20%750.28M3.66%835.49M84.50%806.01M71.12%436.87M-8.00%255.3M249.10%277.5M38.53%79.49M--57.38M
Research and development costs -22.42%2.23B23.63%2.87B25.44%2.32B43.00%1.85B5.98%1.29B99.65%1.22B59.08%611.92M--384.65M
Operating profit 64.79%-909.21M-33.15%-2.58B-4,468.83%-1.94B96.68%-42.44M17.65%-1.28B-148.52%-1.55B-51.17%-624.73M-413.27M
Net non-operating interest income expense 303.25%354.21M-1.63%87.84M86.99%89.29M10.51%47.75M189.48%43.21M1.93%-48.29M0.03%-49.24M-49.26M
Non-operating interest income 138.92%452.84M24.90%189.54M30.71%151.76M13.05%116.1M396.66%102.7M159.06%20.68M75.81%7.98M--4.54M
Non-operating interest expense -3.02%98.62M62.81%101.7M-8.61%62.46M14.89%68.35M-13.74%59.49M20.52%68.97M6.37%57.23M--53.8M
Other net income (expense)
Special income (charges) -1,686.67%-952K108.46%60K40.92%-709K---1.2M--0---3.32M--0--0
-Less:Other special charges 1,686.67%952K-108.46%-60K-40.92%709K--1.2M------3.32M--------
Other non- operating income (expenses) -56.83%-680.09M39.56%-433.64M-86.80%-717.42M23.15%-384.06M88.48%-499.73M-8,403.80%-4.34B58.59%-51.01M---123.2M
Income before tax 47.27%-1.14B17.84%-2.17B-207.64%-2.64B50.07%-858.71M70.71%-1.72B-720.19%-5.87B-31.52%-716.05M-544.46M
Income tax -1,423.69%-116.5M-89.89%8.8M-37.70%87.04M139.71M0
Net income 52.83%-1.03B20.14%-2.18B-173.31%-2.73B41.95%-998.42M70.71%-1.72B-720.19%-5.87B-31.52%-716.05M-544.46M
Net income continuous Operations 52.83%-1.03B20.14%-2.18B-173.31%-2.73B41.95%-998.42M70.71%-1.72B-720.19%-5.87B-31.52%-716.05M---544.46M
Minority interest income 33.98%-101.49M-281.92%-153.73M-40.25M
Net income attributable to the parent company 52.83%-1.03B20.14%-2.18B-173.31%-2.73B41.95%-998.42M70.20%-1.72B-926.38%-5.77B-11.53%-562.32M-504.2M
Preferred stock dividends 0
Other preferred stock dividends 00000000
Net income attributable to common stockholders 52.83%-1.03B20.14%-2.18B-173.31%-2.73B41.95%-998.42M70.20%-1.72B-926.38%-5.77B-11.53%-562.32M-504.2M
Basic earnings per share 54.79%-2.6422.34%-5.84-154.05%-7.5249.32%-2.9691.53%-5.84-3,328.12%-68.96-11.53%-2.0116-1.8037
Diluted earnings per share 54.79%-2.6422.34%-5.84-154.05%-7.5249.32%-2.9691.53%-5.84-3,328.12%-68.96-11.53%-2.0116-1.8037
Dividend per share
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+6.41%
MARA Holdings
MARA
+6.02%
NVIDIA
NVDA
+3.97%
Tesla
TSLA
+3.91%
Coinbase
COIN
+3.48%

Unlock the Full List